Ruxolitinib as first-line treatment in secondary hemophagocytic lymphohistiocytosis: A single patient experience

Jessica Slostad; Patrick Hoversten; Candace L. Haddox; Kamila Cisak; Jonas Paludo; Ayalew Tefferi

doi:10.1002/ajh.24971

Ruxolitinib as first-line treatment in secondary hemophagocytic lymphohistiocytosis: A single patient experience

Jessica Slostad, Patrick Hoversten, Candace L. Haddox, Kamila Cisak, Jonas Paludo, Ayalew Tefferi

Hematology

Research output: Contribution to journal › Letter › peer-review

32 Scopus citations

Original language	English (US)
Pages (from-to)	E47-E49
Journal	American journal of hematology
Volume	93
Issue number	2
DOIs	https://doi.org/10.1002/ajh.24971
State	Published - Feb 2018

ASJC Scopus subject areas

Hematology

Access to Document

10.1002/ajh.24971

Cite this

@article{9fc6bb9e4a1740a2ae5b62a7d8cd643c,

title = "Ruxolitinib as first-line treatment in secondary hemophagocytic lymphohistiocytosis: A single patient experience",

author = "Jessica Slostad and Patrick Hoversten and Haddox, {Candace L.} and Kamila Cisak and Jonas Paludo and Ayalew Tefferi",

year = "2018",

month = feb,

doi = "10.1002/ajh.24971",

language = "English (US)",

volume = "93",

pages = "E47--E49",

journal = "American Journal of Hematology",

issn = "0361-8609",

publisher = "Wiley-Liss Inc.",

number = "2",

}

TY - JOUR

T1 - Ruxolitinib as first-line treatment in secondary hemophagocytic lymphohistiocytosis

T2 - A single patient experience

AU - Slostad, Jessica

AU - Hoversten, Patrick

AU - Haddox, Candace L.

AU - Cisak, Kamila

AU - Paludo, Jonas

AU - Tefferi, Ayalew

PY - 2018/2

Y1 - 2018/2

UR - http://www.scopus.com/inward/record.url?scp=85037350538&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85037350538&partnerID=8YFLogxK

U2 - 10.1002/ajh.24971

DO - 10.1002/ajh.24971

M3 - Letter

C2 - 29134683

AN - SCOPUS:85037350538

VL - 93

SP - E47-E49

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 2

ER -

Ruxolitinib as first-line treatment in secondary hemophagocytic lymphohistiocytosis: A single patient experience

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this